Jonathan Friedberg: The Importance of Continued Screening for Late Effects in Adulthood
Jonathan Friedberg, Director of the Wilmot Cancer Institute, shared a post on X about recent paper by Rusha Bhandari et al., published in Journal of Clinical Oncology.
“Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: These results show the importance of continued screening for late effects in adulthood; further studies of older survivors needed as treatments continue to evolve.”
Title: Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
Authors: Rusha Bhandari, Yan Chen, Eric J. Chow, Rebecca M. Howell, Lisa B. Kenney, Kevin R. Krull, Wendy Leisenring, Paul C. Nathan, Joseph P. Neglia, Kirsten K. Ness, Kevin C. Oeffinger, Claire Snyder, Lucie M. Turcotte, F. Lennie Wong, Yutaka Yasui, Gregory T. Armstrong, Saro H. Armenian
Read The Full Article at Journal of Clinical Oncology.
More posts featuring Jonathan Friedberg on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023